{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:34:45Z","timestamp":1790739285345,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immune profiling is becoming a vital tool for identifying predictive and prognostic markers for translational studies. The study of the tumor microenvironment (TME) in paraffin tumor tissues such as malignant pleural mesothelioma (MPM) could yield insights to actionable targets to improve patient outcome. Here, we optimized and tested a new immune-profiling method to characterize immune cell phenotypes in paraffin tissues and explore the co-localization and spatial distribution between the immune cells within the TME and the stromal or tumor compartments. Tonsil tissues and tissue microarray (TMA) were used to optimize an automated nine-color multiplex immunofluorescence (mIF) panel to study the TME using eight antibodies: PD-L1, PD-1, CD3, CD8, Foxp3, CD68, KI67, and pancytokeratin. To explore the potential role of the cells into the TME with this mIF panel we applied this panel in twelve MPM cases to assess the multiple cell phenotypes obtained from the image analysis and well as their spatial distribution in this cohort. We successful optimized and applied an automated nine-color mIF panel to explore a small set of MPM cases. Image analysis showed a high degree of cell phenotype diversity with immunosuppression patterns in the TME of the MPM cases. Mapping the geographic cell phenotype distribution in the TME, we were able to identify two distinct, complex immune landscapes characterized by specific patterns of cellular distribution as well as cell phenotype interactions with malignant cells. Successful we showed the optimization and reproducibility of our mIF panel and their incorporation for comprehensive TME immune profiling into translational studies that could refine our ability to correlate immunologic phenotypes with specific patterns of cells distribution and distance analysis. Overall, this will improve our ability to understand the behavior of cells within the TME and predict new treatment strategies to improve patient outcome.<\/jats:p>","DOI":"10.1038\/s41598-021-83858-x","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T11:04:11Z","timestamp":1614251051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues"],"prefix":"10.1038","volume":"11","author":[{"given":"Edwin R.","family":"Parra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auriole","family":"Tamegnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renganayaki Krishna","family":"Pandurengan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelia","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Creasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara A.","family":"Vaporciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne L.","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Sepesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Haymaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"83858_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","volume":"14","author":"S Farkona","year":"2016","unstructured":"Farkona, S., Diamandis, E. P. & Blasutig, I. M. Cancer immunotherapy: the beginning of the end of cancer?. BMC Med. 14, 73 (2016).","journal-title":"BMC Med."},{"issue":"8","key":"83858_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8(8), 793\u2013800 (2002).","journal-title":"Nat. Med."},{"issue":"13","key":"83858_CR3","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206(13), 3015\u20133029 (2009).","journal-title":"J. Exp. Med."},{"issue":"1","key":"83858_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui, L. & Chen, Y. Tumor microenvironment: Sanctuary of the devil. Cancer Lett. 368(1), 7\u201313 (2015).","journal-title":"Cancer Lett."},{"issue":"26","key":"83858_CR5","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366(26), 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"83858_CR6","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","volume":"75","author":"MW Teng","year":"2015","unstructured":"Teng, M. W., Ngiow, S. F., Ribas, A. & Smyth, M. J. Classifying Cancers Based on T-cell Infiltration and PD-L1. Cancer Res. 75(11), 2139\u20132145 (2015).","journal-title":"Cancer Res."},{"issue":"7528","key":"83858_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515(7528), 568\u2013571 (2014).","journal-title":"Nature"},{"issue":"12","key":"83858_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/oem.51.12.804","volume":"51","author":"R Spirtas","year":"1994","unstructured":"Spirtas, R. et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup. Environ. Med. 51(12), 804\u2013811 (1994).","journal-title":"Occup. Environ. Med."},{"issue":"6","key":"83858_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/thoraxjnl-2013-203744","volume":"69","author":"A Lacourt","year":"2014","unstructured":"Lacourt, A. et al. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax 69(6), 532\u2013539 (2014).","journal-title":"Thorax"},{"issue":"2\u20133","key":"83858_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","volume":"9","author":"H Yang","year":"2008","unstructured":"Yang, H., Testa, J. R. & Carbone, M. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr. Treat. Options Oncol. 9(2\u20133), 147\u2013157 (2008).","journal-title":"Curr. Treat. Options Oncol."},{"issue":"142","key":"83858_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1183\/16000617.0063-2016","volume":"25","author":"AC Bibby","year":"2016","unstructured":"Bibby, A. C. et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur. Respir. Rev. 25(142), 472\u2013486 (2016).","journal-title":"Eur. Respir. Rev."},{"issue":"4","key":"83858_CR12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/ijms19041041","volume":"19","author":"J Minnema-Luiting","year":"2018","unstructured":"Minnema-Luiting, J., Vroman, H., Aerts, J. & Cornelissen, R. Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma. Int. J. Mol. Sci. 19(4), 1041 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"83858_CR13","first-page":"1007","volume":"61","author":"RA Leigh","year":"1982","unstructured":"Leigh, R. A. & Webster, I. Lymphocytic infiltration of pleural mesothelioma and its significance for survival. S. Afr. Med. J. 61(26), 1007\u20131009 (1982).","journal-title":"S. Afr. Med. J."},{"key":"83858_CR14","doi-asserted-by":"publisher","first-page":"5804230","DOI":"10.1155\/2018\/5804230","volume":"2018","author":"M Tazzari","year":"2018","unstructured":"Tazzari, M. et al. Complex immune contextures characterise malignant peritoneal mesothelioma: loss of adaptive immunological signature in the more aggressive histological types. J. Immunol. Res. 2018, 5804230 (2018).","journal-title":"J. Immunol. Res."},{"issue":"5","key":"83858_CR15","first-page":"1157","volume":"55","author":"L Losi","year":"2019","unstructured":"Losi, L. et al. Role of evaluating tumorinfiltrating lymphocytes, programmed death1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma. Int. J. Oncol. 55(5), 1157\u20131164 (2019).","journal-title":"Int. J. Oncol."},{"issue":"12","key":"83858_CR16","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-11-0407","volume":"17","author":"RR Huang","year":"2011","unstructured":"Huang, R. R. et al. CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 17(12), 4101\u20134109 (2011).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"8","key":"83858_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrc3565","volume":"13","author":"MH Kershaw","year":"2013","unstructured":"Kershaw, M. H., Westwood, J. A. & Darcy, P. K. Gene-engineered T cells for cancer therapy. Nat. Rev. Cancer 13(8), 525\u2013541 (2013).","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"83858_CR18","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1172\/JCI69219","volume":"123","author":"A Kalbasi","year":"2013","unstructured":"Kalbasi, A., June, C. H., Haas, N. & Vapiwala, N. Radiation and immunotherapy: a synergistic combination. J. Clin. Investig. 123(7), 2756\u20132763 (2013).","journal-title":"J. Clin. Investig."},{"issue":"10","key":"83858_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski, T. F., Schreiber, H. & Fu, Y. X. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14(10), 1014\u20131022 (2013).","journal-title":"Nat. Immunol."},{"issue":"2","key":"83858_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/cancers11020247","volume":"11","author":"ER Parra","year":"2019","unstructured":"Parra, E. R., Francisco-Cruz, A. & Wistuba, I. I. State-of-the-art of profiling immune contexture in the era of multiplexed staining and digital analysis to study paraffin tumor tissues. Cancers 11(2), 247 (2019).","journal-title":"Cancers"},{"key":"83858_CR21","first-page":"1","volume-title":"Immunohistochemistry","author":"ER Parra","year":"2018","unstructured":"Parra, E. R. Immune Cell Profiling in Cancer Using Multiplex Immunofluorescence and Digital Analysis Approaches. In Immunohistochemistry (ed. Streckfus, C. F.) 1\u201313 (IntechOpen, Rijeka, 2018)."},{"issue":"2","key":"83858_CR22","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1097\/PAI.0000000000000610","volume":"26","author":"ER Parra","year":"2018","unstructured":"Parra, E. R. Novel technology to assess programmed death-ligand 1 expression by multiplex immunofluorescence and image analysis. Appl. Immunohistochem. Mol. Morphol. 26(2), e22\u2013e24 (2018).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"83858_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/978-1-4939-9773-2_22","volume":"2055","author":"A Francisco-Cruz","year":"2020","unstructured":"Francisco-Cruz, A., Parra, E. R., Tetzlaff, M. T. & Wistuba, I. I. Multiplex immunofluorescence assays. Methods Mol. Biol. 2055, 467\u2013495 (2020).","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"83858_CR24","doi-asserted-by":"publisher","first-page":"13380","DOI":"10.1038\/s41598-017-13942-8","volume":"7","author":"ER Parra","year":"2017","unstructured":"Parra, E. R. et al. Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues. Sci. Rep. 7(1), 13380 (2017).","journal-title":"Sci. Rep."},{"issue":"2","key":"83858_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/cancers12020255","volume":"12","author":"ER Parra","year":"2020","unstructured":"Parra, E. R. et al. Procedural requirements and recommendations for multiplex immunofluorescence tyramide signal amplification assays to support translational oncology studies. Cancers (Basel) 12(2), 83 (2020).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"83858_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/PAI.0000000000000531","volume":"26","author":"ER Parra","year":"2017","unstructured":"Parra, E. R., Villalobos, P., Mino, B. & Rodriguez-Canales, J. Comparison of different antibody clones for immunohistochemistry detection of programmed cell death ligand 1 (PD-L1) on non-small cell lung carcinoma. Appl. Immunohistochem. Mol. Morphol.: AIMM 26(2), 83 (2017).","journal-title":"Appl. Immunohistochem. Mol. Morphol.: AIMM"},{"key":"83858_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2020.06.003","author":"C Behrens","year":"2020","unstructured":"Behrens, C. et al. Female gender predicts augmented immune infiltration in lung adenocarcinoma. Clin Lung Cancer https:\/\/doi.org\/10.1016\/j.cllc.2020.06.003 (2020).","journal-title":"Clin Lung Cancer"},{"issue":"24","key":"83858_CR28","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1158\/1078-0432.CCR-15-2443","volume":"22","author":"ER Parra","year":"2016","unstructured":"Parra, E. R. et al. Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients. Clin Cancer Res 22(24), 6278\u20136289 (2016).","journal-title":"Clin Cancer Res"},{"issue":"19","key":"83858_CR29","doi-asserted-by":"publisher","first-page":"16848","DOI":"10.18632\/oncotarget.4253","volume":"6","author":"S Benedetti","year":"2015","unstructured":"Benedetti, S., Nuvoli, B., Catalani, S. & Galati, R. Reactive oxygen species a double-edged sword for mesothelioma. Oncotarget 6(19), 16848\u201316865 (2015).","journal-title":"Oncotarget"},{"key":"83858_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2016.03.001","volume":"96","author":"S Cedres","year":"2016","unstructured":"Cedres, S. et al. Analysis of expression of PTEN\/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM). Lung Cancer 96, 1\u20136 (2016).","journal-title":"Lung Cancer"},{"issue":"11","key":"83858_CR31","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.jtho.2016.07.033","volume":"11","author":"S Khanna","year":"2016","unstructured":"Khanna, S. et al. Malignant mesothelioma effusions are infiltrated by CD3(+) T cells highly expressing PD-L1 and the PD-L1(+) tumor cells within these effusions are susceptible to ADCC by the anti-PD-L1 antibody avelumab. J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer 11(11), 1993\u20132005 (2016).","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"1","key":"83858_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40425-018-0368-0","volume":"6","author":"ER Parra","year":"2018","unstructured":"Parra, E. R. et al. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J. Immunother. Cancer 6(1), 48 (2018).","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"83858_CR33","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","volume":"29","author":"G Pasello","year":"2018","unstructured":"Pasello, G. et al. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time. Ann. Oncol. 29(5), 1258\u20131265 (2018).","journal-title":"Ann. Oncol."},{"issue":"1","key":"83858_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jtho.2017.09.1968","volume":"13","author":"NS Patil","year":"2018","unstructured":"Patil, N. S. et al. Molecular and histopathological characterization of the tumor immune microenvironment in advanced stage of malignant pleural mesothelioma. J. Thorac. Oncol. 13(1), 124\u2013133 (2018).","journal-title":"J. Thorac. Oncol."},{"issue":"7055","key":"83858_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature03954","volume":"437","author":"G Willimsky","year":"2005","unstructured":"Willimsky, G. & Blankenstein, T. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437(7055), 141\u2013146 (2005).","journal-title":"Nature"},{"issue":"3","key":"83858_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4161\/cbt.4.3.1644","volume":"4","author":"P DeLong","year":"2005","unstructured":"DeLong, P. et al. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma. Cancer Biol. Ther. 4(3), 342\u2013346 (2005).","journal-title":"Cancer Biol. Ther."},{"key":"83858_CR37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi, S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531\u2013562 (2004).","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"83858_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","volume":"35","author":"A Schietinger","year":"2014","unstructured":"Schietinger, A. & Greenberg, P. D. Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol. 35(2), 51\u201360 (2014).","journal-title":"Trends Immunol."},{"issue":"9","key":"83858_CR39","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10(9), 942\u2013949 (2004).","journal-title":"Nat. Med."},{"issue":"6","key":"83858_CR40","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","volume":"174","author":"L Keren","year":"2018","unstructured":"Keren, L. et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell 174(6), 1373\u20131387 (2018).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83858-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83858-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83858-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:04:09Z","timestamp":1670040249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83858-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83858"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83858-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"30 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4530"}}